The epilepsy medication valproate is responsible for "severe malformations" in 2,150 to 4,100 children in France since the drug was first marketed in the country in 1967, according to a preliminary study by French health authorities.
Women who took the drug during pregnancy to treat epilepsy were four times more likely to give birth to babies with congenital malformations, said the report, jointly issued by the French National Agency for the Safety of Medicines (ANSM) and the national health insurance administration.
"The study confirms the highly teratogenic" -- that is, capable of causing birth defects --- "nature of valproate," Mahmoud Zureik, scientific director of ANSM and co-author of the report, told AFP ahead of its release.
GMT 21:55 2018 Tuesday ,23 January
Trump to meet May, Netanyahu, Kagame in Davos: White HouseGMT 21:53 2018 Tuesday ,23 January
S&P 500, Nasdaq end at records as technology shares gainGMT 21:51 2018 Tuesday ,23 January
Venezuela's Maduro says ready to run for second termGMT 21:49 2018 Tuesday ,23 January
Trump to tell Erdogan of concern over Syria offensiveGMT 21:47 2018 Tuesday ,23 January
Trump says NAFTA talks are 'moving along pretty well'GMT 22:13 2018 Monday ,22 January
Senate votes to end US shutdown, bill heads to HouseGMT 22:12 2018 Monday ,22 January
Dow, S&P, Nasdaq finish at records as US goverment shutdown endsGMT 22:10 2018 Monday ,22 January
Turkish soldier killed in Syria operationMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©